Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat type 2 diabetes (but not type 1) in conjunction with exercise...
11 KB (607 words) - 05:27, 10 June 2024
Empagliflozin/linagliptin, sold under the brand name Glyxambi, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It...
9 KB (467 words) - 06:10, 16 July 2024
Metformin (redirect from Linagliptin/metformin)
(Kazano, Vipdomet). Linagliptin combined with metformin hydrochloride is sold under the brand name Jentadueto. As of August 2021, linagliptin/metformin is available...
151 KB (14,475 words) - 01:04, 25 October 2024
Empagliflozin/linagliptin/metformin, sold under the brand name Trijardy XR, is a fixed-dose combination medication used for the treatment of type 2 diabetes...
8 KB (357 words) - 17:49, 22 September 2024
the fixed-dose combinations empagliflozin/linagliptin, empagliflozin/metformin, and empagliflozin/linagliptin/metformin. For cardiovascular death, the...
41 KB (3,676 words) - 19:19, 4 October 2024
Novartis as Galvus) Saxagliptin (FDA approved in 2009, marketed as Onglyza) Linagliptin (FDA approved in 2011, marketed as Tradjenta by Eli Lilly and Company...
16 KB (1,798 words) - 07:40, 1 February 2024
and alogliptin A10BD10 Metformin and saxagliptin A10BD11 Metformin and linagliptin A10BD12 Pioglitazone and sitagliptin A10BD13 Metformin and alogliptin...
6 KB (508 words) - 06:49, 20 December 2023
and dapagliflozin. Another triple combination approval for metformin, linagliptin, and empagliflozin followed in 2020. Diabetes medications have four main...
51 KB (5,305 words) - 19:29, 4 November 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
4 KB (328 words) - 05:24, 6 August 2024
Giotrif (afatinib) Jardiance (empagliflozin) Jentadueto / TrajentaDuo (linagliptin / metformin) Metalyse (tenecteplase) Micardis (telmisartan) Micardis...
40 KB (3,323 words) - 14:28, 25 October 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
48 KB (5,006 words) - 23:51, 7 November 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
16 KB (1,542 words) - 20:53, 21 September 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
29 KB (3,615 words) - 19:03, 2 November 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
72 KB (6,068 words) - 21:55, 6 November 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
5 KB (193 words) - 09:12, 12 September 2024
BI-1356 was undergoing phase III clinical trials; it was released as linagliptin in May 2011. X-ray crystallography has shown that that xanthine type...
44 KB (5,080 words) - 05:49, 11 September 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
3 KB (184 words) - 13:53, 14 June 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
25 KB (2,738 words) - 14:08, 9 October 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
44 KB (3,512 words) - 16:20, 8 November 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
53 KB (4,975 words) - 03:43, 30 September 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
9 KB (521 words) - 02:56, 12 October 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
10 KB (748 words) - 23:39, 16 August 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
20 KB (1,637 words) - 07:49, 5 October 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
29 KB (2,960 words) - 20:56, 4 September 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
9 KB (910 words) - 08:39, 14 July 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
11 KB (777 words) - 05:13, 27 October 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
20 KB (2,167 words) - 15:13, 20 September 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
11 KB (1,108 words) - 07:19, 1 September 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
9 KB (670 words) - 07:48, 5 October 2024
Empagliflozin/linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone Linagliptin/metformin...
11 KB (905 words) - 23:37, 11 September 2024